Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art

Inhibitors of Protein Convertase Subtilisin/Kexin 9 (PCSK9) and Acute Coronary Syndrome (ACS): The State-of-the-Art

Acute Coronary Syndrome (ACS) remains one of the most frequent causes of morbidity and mortality in the world. Although the age- and gender-adjusted incidence of ACS is decreasing, the mortality associated with this condition remains high, especially 1-year after the acute event. Several studies dem...

Full description

Bibliographic Details
Main Authors: Gabriella Iannuzzo, Marco Gentile, Alessandro Bresciani, Vania Mallardo, Anna Di Lorenzo, Pasquale Merone, Gianluigi Cuomo, Mario Pacileo, Filippo M. Sarullo, Elio Venturini, Antonello D’Andrea, Carlo Vigorito, Francesco Giallauria
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
acute coronary syndrome
PCSK9 inhibitors
cardiovascular risk
Online Access:https://www.mdpi.com/2077-0383/10/7/1510

Similar Items

Similar Items